NCBiotech News

Criticality, a young company developing nutraceuticals from specialized North Carolina hemp plants, has launched its inaugural line of consumer cannabidiol (CBD) products, under the brand name Korent.

AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs. 

Grifols, already the largest private employer in Johnston County, is about to get even bigger.

North Carolina’s reputation as “Vaccine Central” has enjoyed an official boost from federal regulators, thanks to marketing approval for Novartis’ flu vaccine using the highly efficient process of cell culture.

Four companies that contribute to North Carolina’s reputation as “Vaccine Central” were 2012 winners of the only dedicated awards honoring the accomplishments of the vaccine industry.

Arbovax, Medicago, Novartis Vaccines and Diagnostics and Quintiles brought home ViE Awards from the fifth World Vaccine Congress. The four were winners from among 14 different categories Wednesday at the Washington, D.C., gathering of more than 350 vaccine executives.

Arbovax, a Raleigh firm developing a Dengue fever vaccine, won for presenting the best poster session.

Boragen, Inc., a boron-based discovery platform company based in RTP, has won a $300,500 Phase I Small Business Innovation Research grant for research on controlling malaria.

Winston-Salem's KeraNetics has received FDA approval for its KeraStat Cream to treat debilitating skin burns from radiation therapy.

Chapel Hill's Path BioAnalytics has joined forces with Australian researchers to study a new drug to fight COVID-19

The North Carolina Biotechnology Center’s Piedmont Triad Office is welcoming seven new thought leaders to its regional advisory committee.

bioMASON is adding a new brick-and-mortar headquarters to its Research Triangle Park brick-and-mortar biotech business.

A new ag industry report from NC State University economist Mike Walden says more than 16%, or $92.7 billion of the $564 billion gross state product, was contributed by the food, natural fiber and forestry industries in 2018. That’s up from $91.8 billion in 2017.

RTP regenerative medicine company Merakris Therapeutics has launched a new skin-graft alternative to help protect and heal wounds.

Raleigh's Bryn Pharma has raised an additional $11 million, for a total of $26 million in this funding round, as it approaches market approval for its epinephrine nasal spray to treat anaphylaxis.

Greensboro-based Scullion Strategy Group and High Point-based Trone Research + Consulting have joined forces to launch a new methodology to assess product marketability, targeting animal health and other life sciences sectors.

An ancient relative of tobacco is at the heart of a new COVID-19 vaccine under development by Medicago and GSK.